Thermo Fisher Scientific Inc. Stock Deutsche Boerse AG
Equities
TN80
CA88355G1000
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.3 EUR | -8.33% | +3.62% | 0.00% |
05-10 | UK Competition Regulator Opens Probe on Thermo Fisher, Olink Merger | MT |
05-10 | UK Competition Watchdog Opens Probe on Thermo Fisher Scientific's Acquisition of Olink | MT |
Sales 2024 * | 43.01B 39.87B 58.82B | Sales 2025 * | 46.08B 42.72B 63.02B | Capitalization | 225B 209B 308B |
---|---|---|---|---|---|
Net income 2024 * | 6.11B 5.67B 8.36B | Net income 2025 * | 7B 6.49B 9.57B | EV / Sales 2024 * | 5.8 x |
Net Debt 2024 * | 23.99B 22.24B 32.81B | Net Debt 2025 * | 19.18B 17.78B 26.24B | EV / Sales 2025 * | 5.31 x |
P/E ratio 2024 * |
37.3
x | P/E ratio 2025 * |
31.8
x | Employees | 122,000 |
Yield 2024 * |
0.25% | Yield 2025 * |
0.28% | Free-Float | 86.04% |
Latest transcript on Thermo Fisher Scientific Inc.
1 day | -8.33% | ||
1 week | +3.62% | ||
Current month | +2.14% | ||
1 month | +1.42% |
Managers | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01-10-31 |
Director of Finance/CFO | 57 | 01-05-31 | |
Ryan Snyder
CTO | Chief Tech/Sci/R&D Officer | - | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01-10-31 |
C. Harris
BRD | Director/Board Member | 67 | 12-03-29 |
Ruby Chandy
BRD | Director/Board Member | 62 | 22-02-28 |
Date | Price | Change |
---|---|---|
24-05-13 | 14.3 | -8.33% |
24-05-10 | 15.6 | +12.23% |
24-05-09 | 13.9 | +0.72% |
24-05-08 | 13.8 | 0.00% |
24-05-07 | 13.8 | 0.00% |
Delayed Quote Deutsche Boerse AG, May 13, 2024 at 09:29 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.76% | 188B | |
+12.90% | 137B | |
+25.95% | 108B | |
+0.34% | 63.19B | |
+11.08% | 52.26B | |
+5.62% | 51B | |
+6.28% | 43.89B | |
+4.80% | 38.07B | |
+26.67% | 31.41B |
- Stock Market
- Equities
- TMO Stock
- TN80 Stock